Clinical Trial Update: Repeated Cross Sectional Surveillance Study To Determine the Respiratory Syncytial Virus (RSV) Immunization Rates in German Infants

View source ↗

Summary

A repeated cross-sectional study sponsored by Sanofi Pasteur to determine respiratory syncytial virus immunization rates in German infants. The trial is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Respiratory Syncytial Virus Immunization | Status: ACTIVE_NOT_RECRUITING